Showing 301-310 of 325 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Early immune and beta cell monitoring predicts treatment response | Benaroya Research Institute at Virginia Mason | S. Alice Long | Cures | 01-August-2019 to 31-July-2025 | $2,499,814.79 |
| Cooperative harmonization and validation of an islet-specific AIM assay | Benaroya Research Institute at Virginia Mason | Karen Cerosaletti | Cures | 01-February-2024 to 31-January-2026 | $299,998.00 |
| Assessing and mitigating T cell recognition of iPSC derived endocrine cells in Type 1 Diabetes | Benaroya Research Institute at Virginia Mason | Eddie James | Cures | 01-June-2024 to 31-May-2026 | $500,000.00 |
| Long-read approaches to identify coding, non-coding, and structural variation that contributes to T1D risk | Benaroya Research Institute at Virginia Mason | Eddie James | Cures | 01-September-2024 to 28-February-2026 | $150,000.00 |
| Defining and applying neo-epitope specific TCRs for engineered cell therapy | Benaroya Research Institute at Virginia Mason | Aïsha Callebaut | Cures | 01-March-2023 to 28-February-2026 | $205,273.00 |
| Clinical Trial of Denosumab for Type 1 Diabetes | Beckman Research Institute of the City of Hope | Rupangi Vasavada | Cures | 01-October-2023 to 30-September-2026 | $2,232,400.00 |
| Non-invasive immunoimaging of islet transplant rejection | Beckman Research Institute of the City of Hope | Fouad Kandeel | Cures | 01-June-2023 to 31-May-2026 | $750,000.00 |
| Exploration of Age-Related Pancreatic Beta Cell Diversity in T1D Using Spatial Transcriptomics | Beckman Research Institute of the City of Hope | Farooq Syed | Cures | 01-October-2024 to 31-January-2026 | $199,999.92 |
| Modulation of beta cell mRNA Translation in Type 1 Diabetes | Beckman Research Institute of the City of Hope | Farooq Syed | Cures | 01-September-2024 to 31-March-2027 | $444,138.25 |
| Combination therapy with STX4 activating small molecules or small activating RNA together with harmine to stimulate beta-cell regeneration and enhance functional beta-cell mass | Beckman Research Institute of the City of Hope | Debbie Thurmond | Cures | 01-October-2025 to 30-September-2028 | $1,050,000.00 |